SARS-CoV-2 vaccine effectiveness from Alpha to Omicron in France: results from a two-year prospective cohort 2020-2022
COVID-19 ECCMID 2023
[00:04:59]
17 April 2023
-
PS088
Long-term safety and effectiveness of the mRNA-1273 booster in the COVE trial
COVID-19 ECCMID 2023
[00:04:33]
17 April 2023
-
PS088
Immune responses in heterologous mRNA and inactivated COVID-19 vaccines compared with homologous inactivated COVID-19 vaccines in adolescents 12-17 years old Immune responses in heterologous mRNA and inactivated COVID-19 vaccines compared with homologous
COVID-19 ECCMID 2023
[00:04:47]
23 April 2022
-
PS087
Immune correlates after single-dose Ad26.COV2.S vaccine in adults
COVID-19 ECCMID 2022
[00:05:01]
23 April 2022
-
PS087
COVID-19 vaccine coverage amongst populations experiencing homelessness in Paris area and Marseille, France: a stratified cross-sectional survey
COVID-19 ECCMID 2022
[00:04:55]
23 April 2022
-
PS087
Vaccine effectiveness against COVID-19-related hospitalisation caused by Omicron among Finnish elderly aged 70 years or more: a register-based cohort study
COVID-19 ECCMID 2022
[00:05:05]
23 April 2022
-
PS087
Inability to work and unexpected side effects of the after first, second and third dose of COVID-19 vaccination in healthcare workers
COVID-19 ECCMID 2022
[00:04:11]
23 April 2022
-
PS087
Immunogenicity and safety of co-administration of COVID-19 and influenza vaccination
COVID-19 ECCMID 2022
[00:03:53]
23 April 2022
-
PS087
Immunogenicity and safety of COVID-19 vaccination in people living with HIV (PLHIV): results of a Slovenian national study
COVID-19 ECCMID 2022
[00:03:34]
23 April 2022
-
PS087
BNT162b2 vaccine: immunogenicity survey among Policlinic San Martino IRCCS healthcare workers
COVID-19 ECCMID 2022
[00:03:38]
23 April 2022
-
PS087
The BNT162b2 mRNA vaccine against SARS-CoV-2 affects both adaptive and innate immune responses
COVID-19 ECCMID 2022
[00:04:29]
23 April 2022
-
PS087
Vaccine effectiveness against hospitalised and severe SARS-CoV-2 variant Delta infections in adults in France: a test-negative case-control study
COVID-19 ECCMID 2022
[00:04:47]
23 April 2022
-
PS087
Humoral immune responses to heterologous or homologous COVID-19 Vaccination
COVID-19 ECCMID 2022
[00:03:25]
23 April 2022
-
PS087
Breakthrough infections in a cohort of patients hospitalised for acute COVID-19
COVID-19 ECCMID 2022
[00:04:00]
23 April 2022
-
PS087
COVID-19 vaccine acceptance in middle and high school students, Auvergne-Rhône-Alpes in June 2021
COVID-19 ECCMID 2022
[00:04:40]
23 April 2022
-
PS087
Evaluation of neutralising antibody response against different SARS-CoV-2 variants in naïve and COVID-19 healthcare workers after BNT162b2 vaccination and unvaccinated COVID-19 subjects
COVID-19 ECCMID 2022
[00:05:00]
23 April 2022
-
PS087
First evidence of on-field effectiveness of BNT162b2 vaccine among healthcare workers of Ospedale Policlinico San Martino IRCCS, Genoa, Italy
COVID-19 ECCMID 2022
[00:04:09]
23 April 2022
-
PS087
Intention to participate in COVID-19 vaccine clinical trial in the general population in France in May 2021
COVID-19 ECCMID 2022
[00:04:48]
23 April 2022
-
PS087
Profile and motivations of volunteers registered on an online platform to participate in COVID-19 vaccine clinical trials in France
COVID-19 ECCMID 2022
[00:04:55]
23 April 2022
-
PS087
T-cell response to SARS-CoV-2 antigen after vaccination in a cohort of HCWs
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.